HK1201440A1 - Methods for reducing the frequency and severity of acute exacerbations of asthma - Google Patents

Methods for reducing the frequency and severity of acute exacerbations of asthma

Info

Publication number
HK1201440A1
HK1201440A1 HK15101910.8A HK15101910A HK1201440A1 HK 1201440 A1 HK1201440 A1 HK 1201440A1 HK 15101910 A HK15101910 A HK 15101910A HK 1201440 A1 HK1201440 A1 HK 1201440A1
Authority
HK
Hong Kong
Prior art keywords
asthma
severity
frequency
reducing
methods
Prior art date
Application number
HK15101910.8A
Other languages
English (en)
Chinese (zh)
Inventor
Nestor Molfino
Joseph Parker
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Publication of HK1201440A1 publication Critical patent/HK1201440A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HK15101910.8A 2011-11-01 2015-02-26 Methods for reducing the frequency and severity of acute exacerbations of asthma HK1201440A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161554110P 2011-11-01 2011-11-01
US201161562544P 2011-11-22 2011-11-22
US201261645699P 2012-05-11 2012-05-11
PCT/US2012/062349 WO2013066780A2 (en) 2011-11-01 2012-10-28 Methods for reducing the frequency and severity of acute exacerbations of asthma

Publications (1)

Publication Number Publication Date
HK1201440A1 true HK1201440A1 (en) 2015-09-04

Family

ID=48193002

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15100471.1A HK1200088A1 (en) 2011-11-01 2015-01-15 Methods for reducing the frequency and severity of acute exacerbations of asthma
HK15101910.8A HK1201440A1 (en) 2011-11-01 2015-02-26 Methods for reducing the frequency and severity of acute exacerbations of asthma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15100471.1A HK1200088A1 (en) 2011-11-01 2015-01-15 Methods for reducing the frequency and severity of acute exacerbations of asthma

Country Status (11)

Country Link
US (1) US20140328839A1 (xx)
EP (1) EP2773374A4 (xx)
JP (1) JP2014533246A (xx)
KR (1) KR20140097217A (xx)
CN (1) CN104039352A (xx)
AU (1) AU2012332859A1 (xx)
CA (1) CA2853858A1 (xx)
HK (2) HK1200088A1 (xx)
MX (1) MX2014004968A (xx)
RU (1) RU2014122189A (xx)
WO (1) WO2013066780A2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6306588B2 (ja) 2012-08-21 2018-04-04 サノフィ・バイオテクノロジー Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
TR201907907T4 (tr) * 2013-08-12 2019-06-21 Astrazeneca Ab Benralizumab kullanarak astımlı hastalarda zorlu ekspiratuar hacmi arttırma yöntemleri.
CN111588848A (zh) * 2013-08-12 2020-08-28 阿斯特拉捷利康股份公司 使用贝那利珠单抗降低哮喘恶化率的方法
RU2728578C2 (ru) 2013-08-12 2020-07-30 Астразенека Аб Способы нормализации симптомов астмы с применением бенрализумаба
BR112016008082A2 (pt) * 2013-10-15 2017-10-17 Medimmune Llc métodos para tratamento de doença pulmonar obstrutiva crônica usando benralizumab
MX2016004605A (es) * 2013-10-24 2016-11-14 Astrazeneca Ab Formulaciones de anticuerpos estables acuosas.
IL247290B (en) * 2014-02-21 2021-06-30 Sanofi Biotechnology Methods of treating or preventing asthma by adding an il-4r antagonist
CA2940295A1 (en) * 2014-02-21 2015-08-27 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
MX2017006286A (es) 2014-11-14 2018-01-23 Sanofi Biotechnology Metodos para tratar sinusitis cronica con polipos nasales por administracion de un antagonista de il-4r.
US20160272706A1 (en) * 2015-01-12 2016-09-22 Medimmune Limited Il-13 binding proteins and uses thereof
JP6895884B2 (ja) * 2015-06-01 2021-06-30 国立大学法人富山大学 肺高血圧症の治療薬及び治療方法
CA3079946A1 (en) 2017-10-30 2019-05-09 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
CN111100210B (zh) * 2019-01-30 2022-04-19 武汉九州钰民医药科技有限公司 一种Fc融合蛋白及其应用
TW202214692A (zh) 2020-06-05 2022-04-16 瑞典商阿斯特捷利康公司 治療患有鼻瘜肉的患者的重度氣喘之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2233974T3 (es) * 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
US6746839B1 (en) * 1998-01-12 2004-06-08 Interleukin Genetics, Inc. Diagnostics and therapeutics for an obstructive airway disease
US20050226867A1 (en) * 2003-10-08 2005-10-13 Kyowa Hakko Kogyo Co., Ltd. IL-5R-specific antibody composition
MX2020011303A (es) * 2007-05-14 2021-12-17 Astrazeneca Ab Metodos para reducir niveles de eosinofilos.

Also Published As

Publication number Publication date
EP2773374A4 (en) 2015-04-29
CA2853858A1 (en) 2013-05-10
JP2014533246A (ja) 2014-12-11
AU2012332859A1 (en) 2014-05-22
US20140328839A1 (en) 2014-11-06
EP2773374A2 (en) 2014-09-10
KR20140097217A (ko) 2014-08-06
WO2013066780A3 (en) 2013-07-04
CN104039352A (zh) 2014-09-10
WO2013066780A2 (en) 2013-05-10
HK1200088A1 (en) 2015-07-31
RU2014122189A (ru) 2015-12-10
MX2014004968A (es) 2014-08-01

Similar Documents

Publication Publication Date Title
HK1201440A1 (en) Methods for reducing the frequency and severity of acute exacerbations of asthma
EP2683857A4 (en) DEVICES AND METHOD FOR PRODUCING FIBERS
EP2715787A4 (en) DEVICES WITH STAIRLESS STEEL STRUCTURES AND METHOD FOR THEIR PRODUCTION
EP2681653A4 (en) METHOD AND APPARATUS FOR CERTIFYING FACTS
EP2670866A4 (en) BIOMARKERS AND METHODS OF USE
EP2797715A4 (en) SHAPED ABRASIVE PARTICLE AND METHOD OF FORMING THE SAME
IL232977A0 (en) Intra-episode dexmedetomidine preparations and methods of using them
HK1191636A1 (zh) 由漿滴形成的支撐劑顆粒及其使用方法
GB201116029D0 (en) Abradable panel and method of forming the same
IL233381A0 (en) Grinding tools and a method for their production
EP2863927A4 (en) COMPOSITIONS AND METHODS FOR REDUCING THE FREQUENCY AND / OR INTENSITY OF THE CEPHALA
GB201004895D0 (en) Consumables and methods of production thereof
EP2696191A4 (en) METHOD FOR THE CHARACTERIZATION AND CLASSIFICATION OF kidney stones
SG11201400405TA (en) Caninised antibodies and method for the production of same
ZA201400943B (en) Apparatus and method of using the same
EP2690064A4 (en) INORGANIC COMPOUND PARTICLES AND METHOD FOR PRODUCING THE SAME
IL232424A0 (en) Process for the preparation of 1-acyl-4-phenylsulfonylprolinamide derivatives and intermediates
GB201004897D0 (en) Consumables and methods of production thereof
EP2744999A4 (en) NOZZLE ARRANGEMENT AND METHOD FOR THE PRODUCTION THEREOF
EP2767120A4 (en) METHOD AND DEVICE FOR OVERLAPPING FREQUENCY BAND REINFORCEMENT
PL2744653T3 (pl) Panel izolowany i sposób jego wytwarzania
GB201004894D0 (en) Consumables and methods of production thereof
GB201004902D0 (en) Consumables and methods of production thereof
GB2487128B (en) Carton and method of assembly thereof
EP2768541A4 (en) PROCESS FOR FORMING DEXTRAN SHEETS AND THROMBIN